Phase II for Technoderma Therepeutic's TDM-105795 set to begin in April tentatively
    Research/Science 4/7/2023

    Phase II for TDM-105795 for Androgenic Alopecia is set to begin in April 2023. The study aims to evaluate the efficacy and safety of TDM-105795 in male subjects.
    View this post in the Community →

    Similar Community Posts Join

    5 / 26 results

    Related Research

    6 / 17 results